Apotex Health Corp. (TSX:APTX)

Apotex Health Revenue

Apotex Health had revenue of 847.98M CAD in the quarter ending June 30, 2026. This brings the company's total for the last twelve months to 3.20B. In the fiscal year ending March 31, 2026, Apotex Health had annual revenue of 3.49B with 4.21% growth. That makes Apotex Health the 4,582nd largest company in the world by revenue and 118th in Canada.

• Revenue (ttm): 3.20B
• Revenue Growth: +4.21%
• P/S Ratio: 2.39
• Revenue / Employee: 532.75K
• Employees: 6,000
• Market Cap: 7.65B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Conventional Generics 1.78B 51.0%
• Specialty Generics 1.15B 33.0%
• Brands & Biosimilars 558.70M 16.0%

By Geography

Chart

• United States (U.S.) 1.79B 51.3%
• Canada 1.43B 41.0%
• Other 269.38M 7.7%

Fiscal year ended Mar 31, 2026 See the full Apotex Health breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	3.49B	141.18M	4.21%
Mar 31, 2025	3.35B	409.20M	13.92%
Mar 31, 2024	2.94B	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 12, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 28, 2026

Data Sources Report a data error